EARLYRAB-LS Capsules is an advanced gastro-protective and prokinetic combination indicated for the effective management of gastroesophageal reflux disease (GERD), functional dyspepsia, chronic gastritis, acid reflux, heartburn, bloating, and nausea. This dual-action formulation provides comprehensive relief by controlling excess gastric acid secretion while improving gastrointestinal motility.

Rabeprazole, a potent proton pump inhibitor (PPI), works by suppressing gastric acid production, offering rapid and long-lasting relief from acidity, epigastric pain, and reflux symptoms. Levosulpride, a selective dopamine D2 receptor antagonist, enhances gastric emptying and intestinal motility, helping relieve symptoms such as post-meal fullness, bloating, nausea, and early satiety.

EARLYRAB-LS is widely prescribed in patients suffering from acid-peptic disorders, non-ulcer dyspepsia, irritable stomach, and GERD associated with delayed gastric emptying. Its balanced composition ensures superior symptom control, improved patient compliance, and excellent tolerability when used as directed.

Marketed by Varmed Pharma Pvt Ltd, a trusted name and one of the Best PCD Pharma Franchise Companies in India, EARLYRAB-LS Capsules is a high-potential product with strong demand among gastroenterologists and general physicians. It is an ideal brand for partners seeking a profitable and fast-moving molecule under the PCD Pharma Franchise / Monopoly Pharma Franchise model.